Session Information
- CKD: Screening, Diagnosis, Serum and Urine Biomarkers, and Scoring Indices
November 07, 2025 | Location: Exhibit Hall, Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: CKD (Non-Dialysis)
- 2301 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention
Background
Chronic Kidney Disease (CKD) has attained epidemic proportions in many countries. Early detection and adequate therapy help slow progression of kidney failure and dialysis-dependent in Kingdom Saudi Arabia (KSA).
Methods
We report data from community CKD screening outreaches in the Saudi Kidney Care Program (KCP) spearheaded by the Saudi Ministry of Health in collaboration with DaVita Care-KSA. Traditional media and digital information outlets achieved public engagement and sensitization regarding the screening program in the Makkah, Madinah, and Jubil. CKD screening of individuals ≥16 years old was performed in public institutions and door-to-door visits. CKD was defined as an estimated glomerular filtration rate ≤ 60ml/min/1.73m2 or urine albumin-creatinine ratio >30mg/g creatinine.
Results
A total of 12,563 adults (30.4% females, mean age 38.8±11.7 years) completed the screening process. Hypertension prevalence was 31.3% (95% CI 30.5 –32.2%), elevated blood glucose 15.1% (14.4 – 15.7%), and obesity 34.1% (33.3– 34.9%). CKD prevalence was 10.7% (10.1 – 11.2%) with a female preponderance, shown in table1. Increasing age (odds ratio 1.03, p<0.001), female sex (OR 1.22, p=0.005), hypertension (OR 2.07, p<0.001), elevated blood glucose (3.14, p<0.001) and CKD family history (1.24, p=0.02) were independently associated with increased CKD risk.
Conclusion
Saudi Arabia, with a high CKD prevalence and young population, is ripe for a sustainable, targeted national CKD screening program.
Table 1: CKD prevalence in select population subgroups
